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A B S T R A C T
Objectives: Sixty years ago, the Association of Osteosynthesis (AO) was founded with the aim to
improve fracture treatment and has since grown into one of the largest medical associations
worldwide. Aim of this study was to evaluate AO's impact on science, education, patient care and the
MedTech business.
Design/methods: Impact evaluations were conducted as appropriate for the individual domains:
Impact on science was measured by analyzing citation frequencies of publications promoted by AO.
Impact on education was evaluated by analyzing the evolution of number and location of AO courses.
Impact on patient care was evaluated with a health economic model analyzing cost changes and
years of life gained through the introduction of osteosynthesis in 17 high-income countries (HICs).
Impact on MedTech business was evaluated by analyzing sales data of AO-associated products.
Results: Thirty-five AO papers and 2 major AO textbooks are cited at remarkable frequencies in high
ranking journals with up to 2000 citations/year. The number of AO courses steadily increased with a total
of 6450000 participants, 20‘000 teaching days and 2‘500 volunteer faculty members so far. The
introduction of osteosynthesis saved at least 925 billion Swiss Francs [CHF] in the 17 HICs analyzed and
had an impact on avoiding premature deaths comparable to the use of antihypertensive drugs. AO-
associated products generated sales of 55 billion CHF.
Conclusion: AO's impact on science, education, patient care, and the MedTech business was significant
because AO addressed hitherto unmet needs by combining activities that mutually enriched and
reinforced each other.
© 2019 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Sixty years ago, a group of 13 visionary Swiss surgeons founded
the Association of Osteosynthesis (AO) with the aim of improving
fracture care [1]. At the time, most surgeons viewed osteosynthesis
with suspicion because it was technically demanding and involved
the risk of infection, so it was deemed too risky. The mainstay of
fracture treatment consisted of conservative treatment. Fractures
were treated with plaster casts and/or in traction so that patients
were immobilized over many weeks. Typical sequelae consisted of
muscle atrophy, stiff joints, loss of range of motion, and often
subsequent invalidity [2].
The founders of AO believed that fracture treatment could be
improved by treating patients operatively. They developed
treatment guidelines stipulating "restoration of the anatomy,
stable fracture fixation, preservation of blood supply and early
pain-free mobilization of limb and patient" [3]. According to AO's
original bylaws, promotion of osteosynthesis should be achieved
by studying issues involving bone fracture treatment, experimen-
tal research, and the exchange of practical and scientific experience
related to osteosynthesis [3].
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The endeavor was successful. Today, osteosynthesis has become
the standard treatment for most fractures in adults and AO has
grown into a global non-profit organization with over 200000
members [1].
So far, no structured analysis has been performed to assess the
impact of the actions defined in the original bylaws and their
possible economic effects. On the occasion of the 60th anniversary
of AO, we initiated a collaboration with the Winterthur Institute of
Health Economics (WIG) [4], selected after an open call for the
project, to evaluate AO's impact on the scientific community and
education, on patient care from a health economic perspective, as
well as on the MedTech business. The funding for the study was
provided by AO as well as WIG.
Methods
Impact on the scientific community
To evaluate AO's impact on the scientific community, we
analyzed the key book and journal publications brought forward by
AO in the time since its foundation.
Citation frequencies of these publications in journals with high
impact factors (IFs) were extracted from InCites, [5] which uses
citation data from Web of Science [6]. Thresholds for the IFs were
set depending on the field of research, i.e., for pre-clinical research
only journals with an IF of >4 were considered, whereas for papers
on clinical topics, the IF needed to be >3.
Journal publications were only included if they had been
published before 2017 and were cited at least 6 times.
To determine "highly cited papers" and "hot papers", thresholds
from InCites were applied. Papers are deemed "highly cited" if they
receive a number of citations that brings them to the top 1% of
papers in the respective research field published in the specified
year. "Hot papers" are papers published in the past 2 years that
received a number of citations in the most recent two-month
period that places them in the top 0.1% of papers in the same field.
Citation frequencies were analyzed separately for books, papers on
pre-clinical topics, and papers on clinical topics.
Additionally, the development of the funding for the different
areas of AO's research was analyzed.
Impact on education
AO's impacton educationwasevaluated byanalyzingtheevolution
of the courses held by AO over time. The number of courses offered in
different locations,  the number of faculty members, as well as the
number of participants registered was determined from AO's archives.
An overview about AO's further educational activities was generated
and its utilization was quantified.
Impact on patient care
The direct impact of AO on patient care is difficult to measure.
However, since it was AO who disseminated the knowledge
about how to successfully implement osteosynthesis (OS), the
impact of OS is a suitable proxy for AO's impact on fracture care.
Therefore, decision tree models were developed to calculate the
differences in direct costs and productivity after treatment with
OS compared to conservative treatment (CONS), assuming a
hypothetical absence of OS, for the 3 index bones femur, tibia
and radius. These 3 index bones were selected as they include
frequent fracture locations of the upper and lower extremities
and have specifically profited from AO innovations. Additionally,
years of life gained (YLG) were calculated for femur and tibia
fractures in analogy to the years of life lost (YLL) concept of the
Global Burden of Disease Study [7].
Input data were derived from Swiss real-world databases and
extrapolated to 16 other high-income countries1 (HICs). Costs were
summed up for the time from AO's inception in 1958 up to 2017.
Based on data availability, the analysis primarily considered the
working population, i.e. patients < 65 years. For proximal femur
fractures, an additional analysis considering patients � 70 years
was performed because these fractures constitute a considerable
and increasing disease burden in HICs [8–10]. These models are
currently getting prepared for publication and a summary of the
key results is presented herein.
Impact on the MedTech business
Using archival sources of the Synthes AG Chur on royalty
payments by the various AO producers and – for the time from
1975 onwards – complemented by historical sales figures provided
by DePuy Synthes, we generated an overview about the develop-
ment of AO's links to the MedTech business and estimated
aggregate sales figures of products developed by AO since the very
beginning of the AO.
Results
Impact on the scientific community
Developing the first edition of the "Manual of internal fixation"
in 1963 [11] and later the "Comprehensive classification of
fractures of long bones" [12] formed the bedrocks of AO's ongoing
impact on the scientific community. The current editions and
successors [11–22] of these publications are still cited at
remarkable frequencies today. Between 2011 and 2016, the citation
frequencies of the "Manual of Internal Fixation" [13–16,20,22] and
its predecessor [11] and successors [17,18] were over 1800 times/
year and of the "Comprehensive Classification of Fractures of Long
Bones" [12,21] over 2000 times/year.
While the initial activities of AO focused on standardizing
fracture treatment, soon pre-clinical research in cell and animal
models and in material sciences was promoted. Fig. 1 depicts the
citation frequencies of AO papers on pre-clinical topics [23–45]
between 2011 and 2016. One of these papers even met the criteria
of a "hot paper" [30].
Before long, research efforts were expanded to include
clinical research. Driven by the change in mindset concerning
evidence-based medicine, clinical research steadily gained
importance. While in 2013, pre-clinical research received
approximately twice the funds of clinical research, nowadays
the funds for pre-clinical and clinical research are nearly equal.
Today, AO invests approximately CHF 25 million for pre-clinical
and clinical research annually. This had a substantial effect on
citation frequencies of publications on clinical topics [46–57]
(Fig. 2).
Of note, AO's impact on the scientific community is not limited
to publications. AO's research institute (ARI) focuses on pre-clinical
research and development and publishes its own journal
(European Cells & Materials, eCM), which also hosts a yearly
conference and has held an IF � 4.0 in 8 of the 10 years since it was
first classified in the Citation Index.
1 Germany$, Austria, Belgium, The Netherlands, Luxemburg, United Kingdom,
Denmark, Norway, Sweden, Finland, US, Canada, Japan, Koreax, Australia, New
Zealand, $Federal Republic of Germany and German Democratic Republic combined
for the time before 1989 x Korea only since 2000, when it became an OECD high
income country
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AO's impact on education
Davos courses
Shortly after AO was founded, the first instructional courses
were held in Davos.
The “Davos Courses” are still AO’s flagship educational
activity. The aim of the courses is to impart knowledge
theoretically and practically. Thus, an important part of the
courses is the "hands-on" training, offering surgeons the
opportunity to use the specific implants and instruments on
sawbones or human specimens.
The first of these courses took place in December 1960 with 66
participants. Quickly, the courses gained popularity in the
international community – almost 90% of participants came from
abroad. In 1969, the number of participants had already risen to
530 and this trend continued (Fig. 3).
The number of course participants between 1960 and 2016
sums up to approximately 650000.
Fig. 2. Citation frequencies of papers on clinical topics in journals with an IF > 3, 2011–2016.
Fig. 1. Citation frequencies of papers on pre-clinical topics in journals with an IF > 4, 2011–2016.
A. Joeris et al. / Injury, Int. J. Care Injured xxx (2019) xxx–xxx 3
G Model
JINJ 8241 No. of Pages 8
Please cite this article in press as: A. Joeris, et al., The impact of the AO Foundation on fracture care: An evaluation of 60 years AO Foundation,
Injury (2019), https://doi.org/10.1016/j.injury.2019.07.016
  A. Joeris et al. / Injury, Int. J. Care Injured 50 (2019) 1868–1875 1871
AO's impact on education
Davos courses
Shortly after AO was founded, the first instructional courses
were held in Davos.
The “Davos Courses” are still AO’s flagship educational
activity. The aim of the courses is to impart knowledge
theoretically and practically. Thus, an important part of the
courses is the "hands-on" training, offering surgeons the
opportunity to use the specific implants and instruments on
sawbones or human specimens.
The first of these courses took place in December 1960 with 66
participants. Quickly, the courses gained popularity in the
international community – almost 90% of participants came from
abroad. In 1969, the number of participants had already risen to
530 and this trend continued (Fig. 3).
The number of course participants between 1960 and 2016
sums up to approximately 650000.
Fig. 2. Citation frequencies of papers on clinical topics in journals with an IF > 3, 2011–2016.
Fig. 1. Citation frequencies of papers on pre-clinical topics in journals with an IF > 4, 2011–2016.
A. Joeris et al. / Injury, Int. J. Care Injured xxx (2019) xxx–xxx 3
G Model
JINJ 8241 No. of Pages 8
Please cite this article in press as: A. Joeris, et al., The impact of the AO Foundation on fracture care: An evaluation of 60 years AO Foundation,
Injury (2019), https://doi.org/10.1016/j.injury.2019.07.016
Worldwide courses
Soon after having established the “Davos courses” in
Switzerland, AO started to organize local AO courses throughout
the world. Despite the “Davos courses” being the main educational
activity, the worldwide courses played an important role in the
dissemination of AO techniques and in fostering the worldwide AO
network.
The first AO course outside Switzerland was held in Germany in
1965, followed by Yugoslavia in 1968, Canada in 1969, and Austria
as well as the US in 1970. Based on the great success, courses
usually continued to be held on a regular basis once they had been
introduced into a country. Courses increased steadily so that by
1994, AO had held courses in 62 countries other than Switzerland.
Fig. 4 shows the introduction of AO courses between 1960 and
1994 by country.
The number of worldwide AO courses increased continuously.
After the millennium it exceeded 200 courses with 100000
participants per year (Fig. 5).
In 2016, AO held 727 courses with 450000 participants
worldwide, excluding the Davos courses.
In total, up to today, AO has held approximately 80700 courses
worldwide with 5800000 participants. Assuming an average course
duration of 2.5 days, this translates into 200000 teaching days,
which were delivered by 20500 volunteer faculty members [58].
Other educational materials and activities
Nowadays, many educational materials are available online.
On one hand, the AO Surgery Reference webpage, which
contains detailed instructions for the complete surgical manage-
ment process for all fractures of any given anatomical region, is a
tool that is used by many surgeons worldwide. By early 2017, the
reference webpage had about 400000 returning visitors per month.
In 2010, the corresponding mobile app was introduced, which has
been downloaded between 60000 and 80000 times per month since
2013. In the first quarter of 2017, it was accessed by approximately
1400000 users per month.
On the other hand, videos, webinars and other online courses
are available on a wide array of topics. The most recent
development is a training program that focuses on research
methodology for clinicians, the AOPEER (Program for Education
and Excellence in Research). This program consists of both online
resources and face-to-face training modules to provide the
appropriate knowledge for surgeons to conduct high quality
clinical research.
Fellowships
Another important way of training surgeons is the fellowship
program, granting individual surgeons scholarships at AO hospi-
tals, i.e., hospitals where experienced AO-affiliated surgeons are
working. The fellows participate in all daily activities and observe
or can even scrub-in on operations. This immersion allows them to
learn the application of AO techniques including their correct
indications directly from highly qualified experts, and thus
guarantees for a learning experience that goes far beyond the
lectures and the practical exercises during the courses.
Introduced in 1971, by 1974 already 86 fellows had taken part in
the program that was first hosted by Swiss hospitals only, and
subsequently expanded rapidly. From 1990 onwards, approximate-
ly 200 surgeons participated each year. Recently, these numbers
have risen further to 296 participants in 2015, hosted by 130
hospitals all over the world (Fig. 6). Up to today, approximately
70800 surgeons have participated in clinical fellowship programs.
To complement the practical training, in 2005, the AO Clinical
Investigation and Documentation (AOCID) institute established a
fellowship program to provide training and experience in clinical
research. Participants spend 3 months full time at AOCID and are
coached by a methodological mentor to complete their own clinical
research project(s). Up to now, AOCID hosted 35 research fellows.
Fig. 3. AO “Davos Courses” participations 1960 to 2016. Included are courses from
all divisions, as well as “special courses” and “symposia”. The years 1995-98 with
missing data and 2008 with an unexplainable outlier were imputed using a
polynomial regression function (marked with "x"). Data source: Schneider R [60],
Schneider R [61], Claudio Gubser, AO, HSG.
Fig. 4. Year of first AO course (up to 1994) by country. Dark colors indicate an early introduction, light colors a late introduction. Data source: Schlich T [62], Schneider R [61].
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Impact on patient care
Modeling total cost differences between OS and CONS for the 3
index bones femur, tibia and radius demonstrated that in all these
fractures, OS resulted in significant savings (Table 1). This was highest
in leg fractures of the working age population (femur: Swiss Francs
[CHF] 1310000/patient, tibia: CHF 1040000/patient), primarily due to
the significant indirect costs caused by prolonged absence from work
inherent in CONS. Of note, even when only direct costs were
considered, treating these fractures operatively would be less
expensive than conservatively. In contrast, the direct costs for treating
radius fractures operatively exceed those of CONS by CHF 40500 per
patient, still resulting in overall savings of CHF 130700/patient.
Extrapolating these figures to 17 HIC (including Switzerland),
the use of OS in femur, tibia and radius fractures alone led to
savings of CHF 925 billion over the last 60 years.
The analysis of YLG was also clearly in favor of OS (Table 2). It was
estimated that the introduction of OS to treat femoral and tibial
fractures resulted in a total of 77.6 million YLG in the 17 HICs
analyzed. Translating these figures into premature deaths avoided in
the US alone in 2001 shows that treating femur and tibia fractures in
patients < 65 years with OS saved 20600 lives and treating proximal
femur fractures with OS in patients � 70 years saved 1260000 lives.
Impact on the MedTech business
In addition to its educational and research activities, which
enabled developing innovative yet reliable OS products, AO
supervised production, marketing and sales of the latter and got
in contact with potential manufacturers right in its beginnings.
They established the non-profit company Synthes AG in Chur,
which received all current and future intellectual property rights
for instruments and implants developed by AO. In exchange to
royalty payments, the Synthes AG granted exclusive production
rights to Mathys and Straumann, who were the first to produce and
sell AO equipment under the "Synthes" brand.
Fig. 5. Yearly number of AO courses (left) and participants (right) 1980 to 2016 worldwide (excluding Davos courses). Included are courses for surgeons from all divisions,
“special courses”, seminars, symposia, and, from 2008 onwards, webinars. Missing data (marked with "x") were imputed using a polynomial regression function. Data source:
Claudio Gubser, AO, AO Community Development Managers.
Fig. 6. Yearly AO fellowships 1971–2017. For the years marked with "x" only
aggregate data (1971–1974) or no data (2003–2008) is available. Missing data were
imputed using a polynomial regression function (marked with "x"). For the years
2010 onwards, only trauma-fellowships are reported due to lacking data for other
divisions. Data source: Schlich T [62], Schneider R [61], AO Annual reports, AO
Community Development Managers.
Table 1
Savings through the introduction of osteosynthesis.1958–2017.
Fracture location Savings in Switzerland
direct costs [CHF] per
patient
Savings in Switzerland
indirect costs [CHF] per
patient
Savings in Switzerland
total costs [CHF] per
patient
Savings in
Switzerland total
costs [CHF]
Savings in USA
total costs
[CHF]
Savings in 17
HICs* total
costs [CHF]
Femur, age <65 4'000 127'000 131'000 5 billion 122 billion 272 billion
Proximal femur, age � 70 3'000 Not included in calculation
(retired)
3'000 1.1 billion 32 billion 69 billion
Tibia, age <65 2'000 102'000 104'000 9.8 billion 223 billion 507 billion
Radius, age <65 �4'500 18'200 13'700 1.5 billion 30 billion 77 billion
Costs are in Swiss Francs (CHF); official 2017 conversion rate to US$: 1.026; source: https://www.exchange-rates.org/Rate/USD/CHF/12-31-2017.
* Switzerland, Germany$, Austria, Belgium, The Netherlands, Luxemburg, United Kingdom, Denmark, Norway, Sweden, Finland, US, Canada, Japan, Koreax, Australia, New
Zealand, $FederalRepublic of Germanyand German DemocraticRepublic combined for the time before 1989 xKorea onlysince2000, whenit became anOECD high income country.
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Synthes brand sales, which comprised products manufactured
and sold by various producers, increased exponentially over time
and were not only a reliable source for funding AO's activities but
also generated a large international business. From 1958–2017,
overall Synthes brand sales amounted to approximately CHF 55
billion.
Discussion
Impact on the scientific community
AO furthered a high number of publications with high citation
frequencies. Figures show that the early books "The Comprehen-
sive Classification of Fractures of Long Bones" [12] and “The
Manual of Internal Fixation” [16] and two journal publications
from the nineties and 2000s are still highly relevant today.
Furthermore, numerous more recent pre-clinical and clinical
papers have been and are cited at high frequencies. Increasing
numbers of papers have been published in high impact journals
and many of them have received high citation rankings.
The main limitation of this analysis is that no figures are
available to illustrate the proportional contribution of AO
compared to the total of publications in a given research field.
Notwithstanding, many AO papers are ranked as "highly cited" or
even "hot paper". These proportional measures indicate the
importance of AO's contributions relative to other papers in the
research field.
Impact on education
The aim of AO courses has always been to disseminate
knowledge along with practical skills in fracture treatment and
has more recently been complemented with education in research
methodology. As demonstrated by the increasing number of
courses held in various parts of the world and rising numbers of
participants, this was perceived well in the community. The ever-
growing popularity of the AO courses suggests that they satisfied
previously unmet needs. AO courses are nowadays CME accredited
in many countries; in some countries, attendance of one or more
AO courses is even compulsory for board certification of
orthopedic surgeons [58]. Experts estimate that if AO were put
together as a full-blown medical school, it would, at a minimum,
equal a medium-sized institution [58].
Additionally, AO's increased activities in low- and middle-
income countries play an important role in providing advanced
education in regions where appropriate medical training is a scarce
resource.
Impact on patient care
In our impact evaluation we used the effect of the technology
"osteosynthesis" as a proxy for AO's impact on patient care.
To assess cost savings, we used combined estimates (femur,
tibia and radius fractures in the population age <65 years and
proximal femur fractures in patients aged � 70). This showed that
in 17 HICs alone, introduction of the technology OS resulted in a
potential net benefit of 925 billion CHF and 77.6 million YLG over
the last 60 years. Not many studies have evaluated the impact of
medical innovations of a similar magnitude. One of these studies
assessed the impact of antihypertensive drugs in the US by
quantifying the number of premature deaths avoided [59]. The
study estimated that treatment with antihypertensive drugs saved
860000 lives in the population aged 30–79 years in 2001. We
estimated for the same time frame, that OS in the US avoided 20600
premature deaths in persons < 65 years and 1260000 premature
deaths in persons � 70 years.
The main limitation of our approach is that the modeling is
based on several assumptions and simplifications. However,
appropriate measures including various sensitivity analyses
were taken to test the robustness of our estimations. Overall, the
underlying assumptions were rather conservative, e.g., we only
included 3 index bones in 17 HICs and indirect costs of unpaid
work were not considered. Thus, the overall impact of OS is
likely to be even bigger. Additionally, the AO founders were not
the first surgeons believing in the benefits of OS. Others such as
Lambotte, Danis or Küntscher also propagated the idea of
treating fractures with OS, even though their ideas and efforts
did not gain a comparable spread. It seems possible that another
organization may have formed and stepped into the breach to
further develop and promote the technology. Nowadays, several
large manufacturers provide OS products developed indepen-
dently of AO or Synthes. It is impossible, however, to tell
whether or how long it would have taken for OS to gain a
comparable spread around the world without AO's efforts that
comprised the exceptional combination of research, education
and manufacturing.
Impact on MedTech business and synergistic effects
AO's involvement in the Synthes brand allowed the manufac-
turers to grow rapidly and generate a large international business.
Synthes branded products alone, generated sales of approximately
CHF 55 billion since AO's foundation. The combination of activities
leading up to this was unique. High quality research formed the
basis to develop successful surgical techniques, corresponding
implants and instruments as well as training on how to use these in
theory and practice.
Conclusion
In the 60 years since its inception, AO has grown from a small
Swiss association comprising a handful of pioneer surgeons into a
globally active foundation with over 200000 members worldwide.
Our analysis shows that AO's impact on science, education,
patient care, and finally the MedTech business was significant. This
was only possible because AO addressed hitherto unmet needs by
combining activities that mutually enriched and reinforced each
other. In doing so, AO furthered the safe and effective use of OS,
which led to a paradigm shift in fracture treatment and ultimately
improved patient care all over the world.
Table 2
Years of life gained (YLG) through the introduction of osteosynthesis 1958–2017. LYG are calculated based on the statistical life expectancies of the respective populations.
Fracture location Total YLG in Switzerland Total YLG in USA Total YLG in 17 HICs*
Femur, age <65 40'000 929’000 2.5 million
Proximal femur, age � 70 0.9 million 29 million 73 million
Tibia, age <65 37'000 758’000 2.1 million
* Switzerland, Germany$, Austria, Belgium, The Netherlands, Luxemburg, United Kingdom, Denmark, Norway, Sweden, Finland, US, Canada, Japan, Koreax, Australia, New
Zealand, $Federal Republic of Germany and German Democratic Republic combined for the time before 1989 x Korea only since 2000, when it became an OECD high income
country.
6 A. Joeris et al. / Injury, Int. J. Care Injured xxx (2019) xxx–xxx
G Model
JINJ 8241 No. of Pages 8
Please cite this article in press as: A. Joeris, et al., The impact of the AO Foundation on fracture care: An evaluation of 60 years AO Foundation,
Injury (2019), https://doi.org/10.1016/j.injury.2019.07.016
1874  A. Joeris et al. / Injury, Int. J. Care Injured 50 (2019) 1868–1875
Sources of funding
This study was partly funded by the AO Foundation,
Switzerland. Additional funding was provided by internal sources
of the Winterthur Institute of Health Economics, Zurich University
of Applied Sciences, Switzerland.
Declaration of competing interest
Alexander Joeris and Eberhard Denk are employees of the AO
Foundation. Nikolaus Renner is Immediate Past President of the AO
Foundation and Felix Gutzwiller has received personal fees from the
AO Foundation (advisory board). Urs Brügger, Klaus Eichler, Marc
Höglinger, Fabio Knöfler and Flurina Meier are employees of WIG,
which has received a grant from the AO Foundation. Klaus Eichlerhas
also received personal fees from the AO Foundation to attend an
expert meeting. The other authors have nothing to disclose.
Acknowledgements
We thank the Steering Committee for methodological and
scientific advice and Elke Rometsch (AOCID) for preparation of the
manuscript. Further, we are grateful for methodological advice,
provision of historical data and content knowledge of the following
people (in alphabetical order): Erica Accola (AO Foundation,
Davos); Laurent Audigé (Klinik Schulthess, Zürich); Isabella
Badrutt (Executive Assistant ARI, AO Foundation); Suthorn
Bavonratanavech (AO Foundation, Davos); Claudio Gubser (AO
Foundation, Davos); Urs Jann (AO Foundation, Davos); Jean-Pierre
Jeannet (Professor Emeritus IMD Institute, Lausanne); Ladina
Lanker (AO Foundation, Davos); Peter Matter (AO Foundation,
Davos); Christoph Nötzli (AO Foundation, Davos); Stefan Ober-
holzer (Global AO Relationship Leader, DePuy Synthes [J&J],
Zuchwil); Stephan Perren (former director of LESD and ARI);
Michael R. Redies (AOTrauma International, Dübendorf); Geoff
Richards (Director of ARI, AO Foundation); Urs Rüetschi (Director
AO Education Institute, Dübendorf).
References
[1] Jeannet J-P. A brief overview of the AO organization (chapter 3). Leading a
Surgical Revolution the AO Foundation – Social Entrepreneurs in the
Treatment of Bone Trauma. Cham: Springer Nature Switzerland; 2019. p. 15–9.
[2] Jeannet J-P. Treatment of bone fractures prior to 1960 (chapter 4). Leading a
Surgical Revolution The AO Foundation Social Entrepreneurs in the Treatment
of Bone Trauma. Cham: Springer Nature Switzerland; 2019. p. 21–31.
[3] Jeannet J-P. AO Formulates Its Credo (Chapter 8). Leading a Surgical Revolution
The AO Foundation – Social Entrepreneurs in the Treatment of Bone Trauma.
Cham: Springer Nature Switzerland; 2019. p. 61–72.
[4] Winterthurer Institut für Gesundheitsökonomie (WIG), Zürcher Hochschule
für Angewandte Wissenschaften (ZHAW). https://wwwzhawch/de/sml/
institute-zentren/wig/.
[5] Clarivate analytics. InCites.
[6] Clarivate analytics. Web of Science.
[7] Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med
2013;369:448–57.
[8] Flikweert ER, Wendt KW, Diercks RL, Izaks GJ, Landsheer D, Stevens M, et al.
Complications after hip fracture surgery: are they preventable? Eur J Trauma
Emergency Surg 2018;44:573–80.
[9] Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, et al. Zoledronic
acid and clinical fractures and mortality after hip fracture. N Engl J Med
2007;357:1799–809.
[10] Suhm N, Kaelin R, Studer P, Wang Q, Kressig RW, Rikli D, et al. Orthogeriatric
care pathway: a prospective survey of impact on length of stay, mortality and
institutionalisation. Arch Orthop Trauma Surg 2014;134:1261–9.
[11] Müller ME, Allgöwer M, Willenegger H. Technik der operativen
Frakturenbehandlung. 1 ed. Berlin, Heidelberg: Springer; 1963.
[12] Müller ME, Nazarian S, Koch P, Schatzker J. The comprehensive classification of
fractures of long bones. Berlin, Heidelberg: Springer; 1990.
[13] Müller ME, Allgöwer M, Willenegger H. Manual der Osteosynthese. AO-
Technik. 1 ed. Berlin, Heidelberg: Springer; 1969.
[14] Müller ME, Allgöwer M, Willenegger H. Manual of internal fixation. Technique
recommended by the AO-group Swiss Association for the study of internal
fixation: ASIF. 1 ed. Berlin, Heidelberg: Springer; 1970.
[15] Müller ME, Allgöwer M, Schneider S, Willenegger H. Manual of internal
fixation. Techniques recommended by the AO Group. 2 ed. Berlin, Heidelberg:
Springer; 1979.
[16] Müller ME, Allgöwer M, Schneider R, Willenegger H. Manual of internal
fixation. Techniques recommended by the AO-ASIF Group. 3 ed. Berlin,
Heidelberg: Springer; 1991.
[17] Rüedi TP, Murphy WM. AO principles of fracture management. 1 ed. Stuttgart,
New York: Thieme; 2000.
[18] Rüedi TP, Buckley RE, Moran CG. AO principles of fracture management. 2 ed.
Stuttgart, New York: Thieme; 2007.
[19] Buckley RE, Moran CG, Apivatthakakul T. AO principles of fracture
management. 3 ed. Stuttgart, New York: Thieme; 2018.
[20] Müller ME, Allgöwer M, Schneider R, Willenegger H. Manual der
Osteosynthese. AO-Technik. 2 ed. Berlin, Heidelberg, New York: Springer; 1977.
[21] Müller M, Nazarian S, Koch P. Classification AO des fractures - les os longs. 1 ed
Berlin: Springer-Verlag; 1987.
[22] Müller ME, Allgöwer M, Schneider R, Willenegger H. Manual der
Osteosynthese. AO Technik. 3 ed. Berlin, Heidelberg: Springer; 1992.
[23] Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, et al.
The human lumbar intervertebral disc: evidence for changes in the
biosynthesis and denaturation of the extracellular matrix with growth,
maturation, ageing, and degeneration. J Clin Invest 1996;98:996–1003.
[24] Bowles RD, Gebhard HH, Hartl R, Bonassar LJ. Tissue-engineered intervertebral
discs produce new matrix, maintain disc height, and restore biomechanical
function to the rodent spine. Proc Natl Acad Sci USA 2011;108:13106–11.
[25] Bruderer M, Richards RG, Alini M, Stoddart MJ. Role and regulation of RUNX2 in
osteogenesis. Eur Cell Mater 2014;28:269–86.
[26] Czekanska EM, Ralphs JR, Alini M, Stoddart MJ. Enhancing inflammatory and
chemotactic signals to regulate bone regeneration. Eur Cell Mater 2014;28:320–34.
[27] Gawri R, Antoniou J, Ouellet J, Awwad W, Steffen T, Roughley P, et al. Best paper
NASS 2013: link-N can stimulate proteoglycan synthesis in the degenerated
human intervertebral discs. Eur Cell Mater 2013;26:107–19 discussion 19.
[28] Gedbjerg N, LaRosa R, Hunter JG, Varrone JJ, Kates SL, Schwarz EM, et al. Anti-
glucosaminidase IgG in sera as a biomarker of host immunity against
Staphylococcus aureus in orthopaedic surgery patients. J Bone Joint Surg Am
2013;95:e171.
[29] Granger N, Blamires H, Franklin RJ, Jeffery ND. Autologous olfactory mucosal
cell transplants in clinical spinal cord injury: a randomized double-blinded
trial in a canine translational model. Brain: J Neurol 2012;135:3227–37.
[30] Inzana JA, Olvera D, Fuller SM, Kelly JP, Graeve OA, Schwarz EM, et al. 3D
printing of composite calcium phosphate and collagen scaffolds for bone
regeneration. Biomaterials 2014;35:4026–34.
[31] Inzana JA, Trombetta RP, Schwarz EM, Kates SL, Awad HA. 3D printed
bioceramics for dual antibiotic delivery to treat implant-associated bone
infection. eCM: eCM Meeting Abstracts 2015, Collection 5. p..
[32] Johnstone B, Alini M, Cucchiarini M, Dodge GR, Eglin D, Guilak F, et al. Tissue
engineering for articular cartilage repair–the state of the art. Eur Cell Mater
2013;25:248–67.
[33] Li Z, Kupcsik L, Yao SJ, Alini M, Stoddart MJ. Mechanical load modulates
chondrogenesis of human mesenchymal stem cells through the TGF-beta
pathway. J Cell Mol Med 2010;14:1338–46.
[34] Loebel C, Czekanska EM, Bruderer M, Salzmann G, Alini M, Stoddart MJ. In vitro
osteogenic potential of human mesenchymal stem cells is predicted by Runx2/
Sox9 ratio. Tissue Eng Part A 2015;21:115–23.
[35] Mortisen D, Peroglio M, Alini M, Eglin D. Tailoring thermoreversible
hyaluronan hydrogels by "click" chemistry and RAFT polymerization for cell
and drug therapy. Biomacromolecules 2010;11:1261–72.
[36] Muller J, Schenk R, Willenegger H. [Experimental studies on the development of
reactive pseudarthroses on the canine radius]. Helv Chir Acta 1968;35:301–8.
[37] Pattappa G, Peroglio M, Sakai D, Mochida J, Benneker LM, Alini M, et al. CCL5/
RANTES is a key chemoattractant released by degenerative intervertebral discs
in organ culture. Eur Cell Mater 2014;27:124–36 discussion 36.
[38] Perren SM, Huggler A, Russenberger M, Allgöwer M, Mathys R, Schenk R, et al.
The reaction of cortical bone to compression Reaktion der Kortikalis auf
Kompression. Acta Orthop Scand Suppl 1969;19–28.
[39] Pirvu T, Blanquer SB, Benneker LM, Grijpma DW, Richards RG, Alini M, et al. A
combined biomaterial and cellular approach for annulus fibrosus rupture
repair. Biomaterials 2015;42:11–9.
[40] Reizner W, Hunter JG, O’Malley NT, Southgate RD, Schwarz EM, Kates SL. A
systematic review of animal models for Staphylococcus aureus osteomyelitis.
Eur Cell Mater 2014;27:196–212.
[41] Sakai D, Nakamura Y, Nakai T, Mishima T, Kato S, Grad S, et al. Exhaustion of
nucleus pulposus progenitor cells with ageing and degeneration of the
intervertebral disc. Nat Commun 2012;3:1264.
[42] Sample SJ, Behan M, Smith L, Oldenhoff WE, Markel MD, Kalscheur VL, et al.
Functional adaptation to loading of a single bone is neuronally regulated and
involves multiple bones. J Bone Mineral Res 2008;23:1372–81.
[43] Schenk R, Willenegger H. (On the histology of primary bone healing.).
Langenbecks ArchKlinChir VerDtschZChir 1964;308:440–52.
[44] Verrier S, Meury TR, Kupcsik L, Heini P, Stoll T, Alini M. Platelet-released
supernatant induces osteoblastic differentiation of human mesenchymal stem
cells: potential role of BMP-2. Eur Cell Mater 2010;20:403–14.
[45] Wirth AJ, Goldhahn J, Flaig C, Arbenz P, Muller R, et al. Implant stability is
affected by local bone microstructural quality. Bone 2011;49:473–8.
[46] Allgower M, Spiegel PG. Internal fixation of fractures: evolution of concepts.
Clin Orthop Relat Res 1979;26–9.
A. Joeris et al. / Injury, Int. J. Care Injured xxx (2019) xxx–xxx 7
G Model
JINJ 8241 No. of Pages 8
Please cite this article in press as: A. Joeris, et al., The impact of the AO Foundation on fracture care: An evaluation of 60 years AO Foundation,
Injury (2019), https://doi.org/10.1016/j.injury.2019.07.016
  A. Joeris et al. / Injury, Int. J. Care Injured 50 (2019) 1868–1875 1875
Sources of funding
This study was partly funded by the AO Foundation,
Switzerland. Additional funding was provided by internal sources
of the Winterthur Institute of Health Economics, Zurich University
of Applied Sciences, Switzerland.
Declaration of competing interest
Alexander Joeris and Eberhard Denk are employees of the AO
Foundation. Nikolaus Renner is Immediate Past President of the AO
Foundation and Felix Gutzwiller has received personal fees from the
AO Foundation (advisory board). Urs Brügger, Klaus Eichler, Marc
Höglinger, Fabio Knöfler and Flurina Meier are employees of WIG,
which has received a grant from the AO Foundation. Klaus Eichlerhas
also received personal fees from the AO Foundation to attend an
expert meeting. The other authors have nothing to disclose.
Acknowledgements
We thank the Steering Committee for methodological and
scientific advice and Elke Rometsch (AOCID) for preparation of the
manuscript. Further, we are grateful for methodological advice,
provision of historical data and content knowledge of the following
people (in alphabetical order): Erica Accola (AO Foundation,
Davos); Laurent Audigé (Klinik Schulthess, Zürich); Isabella
Badrutt (Executive Assistant ARI, AO Foundation); Suthorn
Bavonratanavech (AO Foundation, Davos); Claudio Gubser (AO
Foundation, Davos); Urs Jann (AO Foundation, Davos); Jean-Pierre
Jeannet (Professor Emeritus IMD Institute, Lausanne); Ladina
Lanker (AO Foundation, Davos); Peter Matter (AO Foundation,
Davos); Christoph Nötzli (AO Foundation, Davos); Stefan Ober-
holzer (Global AO Relationship Leader, DePuy Synthes [J&J],
Zuchwil); Stephan Perren (former director of LESD and ARI);
Michael R. Redies (AOTrauma International, Dübendorf); Geoff
Richards (Director of ARI, AO Foundation); Urs Rüetschi (Director
AO Education Institute, Dübendorf).
References
[1] Jeannet J-P. A brief overview of the AO organization (chapter 3). Leading a
Surgical Revolution the AO Foundation – Social Entrepreneurs in the
Treatment of Bone Trauma. Cham: Springer Nature Switzerland; 2019. p. 15–9.
[2] Jeannet J-P. Treatment of bone fractures prior to 1960 (chapter 4). Leading a
Surgical Revolution The AO Foundation Social Entrepreneurs in the Treatment
of Bone Trauma. Cham: Springer Nature Switzerland; 2019. p. 21–31.
[3] Jeannet J-P. AO Formulates Its Credo (Chapter 8). Leading a Surgical Revolution
The AO Foundation – Social Entrepreneurs in the Treatment of Bone Trauma.
Cham: Springer Nature Switzerland; 2019. p. 61–72.
[4] Winterthurer Institut für Gesundheitsökonomie (WIG), Zürcher Hochschule
für Angewandte Wissenschaften (ZHAW). https://wwwzhawch/de/sml/
institute-zentren/wig/.
[5] Clarivate analytics. InCites.
[6] Clarivate analytics. Web of Science.
[7] Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med
2013;369:448–57.
[8] Flikweert ER, Wendt KW, Diercks RL, Izaks GJ, Landsheer D, Stevens M, et al.
Complications after hip fracture surgery: are they preventable? Eur J Trauma
Emergency Surg 2018;44:573–80.
[9] Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, et al. Zoledronic
acid and clinical fractures and mortality after hip fracture. N Engl J Med
2007;357:1799–809.
[10] Suhm N, Kaelin R, Studer P, Wang Q, Kressig RW, Rikli D, et al. Orthogeriatric
care pathway: a prospective survey of impact on length of stay, mortality and
institutionalisation. Arch Orthop Trauma Surg 2014;134:1261–9.
[11] Müller ME, Allgöwer M, Willenegger H. Technik der operativen
Frakturenbehandlung. 1 ed. Berlin, Heidelberg: Springer; 1963.
[12] Müller ME, Nazarian S, Koch P, Schatzker J. The comprehensive classification of
fractures of long bones. Berlin, Heidelberg: Springer; 1990.
[13] Müller ME, Allgöwer M, Willenegger H. Manual der Osteosynthese. AO-
Technik. 1 ed. Berlin, Heidelberg: Springer; 1969.
[14] Müller ME, Allgöwer M, Willenegger H. Manual of internal fixation. Technique
recommended by the AO-group Swiss Association for the study of internal
fixation: ASIF. 1 ed. Berlin, Heidelberg: Springer; 1970.
[15] Müller ME, Allgöwer M, Schneider S, Willenegger H. Manual of internal
fixation. Techniques recommended by the AO Group. 2 ed. Berlin, Heidelberg:
Springer; 1979.
[16] Müller ME, Allgöwer M, Schneider R, Willenegger H. Manual of internal
fixation. Techniques recommended by the AO-ASIF Group. 3 ed. Berlin,
Heidelberg: Springer; 1991.
[17] Rüedi TP, Murphy WM. AO principles of fracture management. 1 ed. Stuttgart,
New York: Thieme; 2000.
[18] Rüedi TP, Buckley RE, Moran CG. AO principles of fracture management. 2 ed.
Stuttgart, New York: Thieme; 2007.
[19] Buckley RE, Moran CG, Apivatthakakul T. AO principles of fracture
management. 3 ed. Stuttgart, New York: Thieme; 2018.
[20] Müller ME, Allgöwer M, Schneider R, Willenegger H. Manual der
Osteosynthese. AO-Technik. 2 ed. Berlin, Heidelberg, New York: Springer; 1977.
[21] Müller M, Nazarian S, Koch P. Classification AO des fractures - les os longs. 1 ed
Berlin: Springer-Verlag; 1987.
[22] Müller ME, Allgöwer M, Schneider R, Willenegger H. Manual der
Osteosynthese. AO Technik. 3 ed. Berlin, Heidelberg: Springer; 1992.
[23] Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, et al.
The human lumbar intervertebral disc: evidence for changes in the
biosynthesis and denaturation of the extracellular matrix with growth,
maturation, ageing, and degeneration. J Clin Invest 1996;98:996–1003.
[24] Bowles RD, Gebhard HH, Hartl R, Bonassar LJ. Tissue-engineered intervertebral
discs produce new matrix, maintain disc height, and restore biomechanical
function to the rodent spine. Proc Natl Acad Sci USA 2011;108:13106–11.
[25] Bruderer M, Richards RG, Alini M, Stoddart MJ. Role and regulation of RUNX2 in
osteogenesis. Eur Cell Mater 2014;28:269–86.
[26] Czekanska EM, Ralphs JR, Alini M, Stoddart MJ. Enhancing inflammatory and
chemotactic signals to regulate bone regeneration. Eur Cell Mater 2014;28:320–34.
[27] Gawri R, Antoniou J, Ouellet J, Awwad W, Steffen T, Roughley P, et al. Best paper
NASS 2013: link-N can stimulate proteoglycan synthesis in the degenerated
human intervertebral discs. Eur Cell Mater 2013;26:107–19 discussion 19.
[28] Gedbjerg N, LaRosa R, Hunter JG, Varrone JJ, Kates SL, Schwarz EM, et al. Anti-
glucosaminidase IgG in sera as a biomarker of host immunity against
Staphylococcus aureus in orthopaedic surgery patients. J Bone Joint Surg Am
2013;95:e171.
[29] Granger N, Blamires H, Franklin RJ, Jeffery ND. Autologous olfactory mucosal
cell transplants in clinical spinal cord injury: a randomized double-blinded
trial in a canine translational model. Brain: J Neurol 2012;135:3227–37.
[30] Inzana JA, Olvera D, Fuller SM, Kelly JP, Graeve OA, Schwarz EM, et al. 3D
printing of composite calcium phosphate and collagen scaffolds for bone
regeneration. Biomaterials 2014;35:4026–34.
[31] Inzana JA, Trombetta RP, Schwarz EM, Kates SL, Awad HA. 3D printed
bioceramics for dual antibiotic delivery to treat implant-associated bone
infection. eCM: eCM Meeting Abstracts 2015, Collection 5. p..
[32] Johnstone B, Alini M, Cucchiarini M, Dodge GR, Eglin D, Guilak F, et al. Tissue
engineering for articular cartilage repair–the state of the art. Eur Cell Mater
2013;25:248–67.
[33] Li Z, Kupcsik L, Yao SJ, Alini M, Stoddart MJ. Mechanical load modulates
chondrogenesis of human mesenchymal stem cells through the TGF-beta
pathway. J Cell Mol Med 2010;14:1338–46.
[34] Loebel C, Czekanska EM, Bruderer M, Salzmann G, Alini M, Stoddart MJ. In vitro
osteogenic potential of human mesenchymal stem cells is predicted by Runx2/
Sox9 ratio. Tissue Eng Part A 2015;21:115–23.
[35] Mortisen D, Peroglio M, Alini M, Eglin D. Tailoring thermoreversible
hyaluronan hydrogels by "click" chemistry and RAFT polymerization for cell
and drug therapy. Biomacromolecules 2010;11:1261–72.
[36] Muller J, Schenk R, Willenegger H. [Experimental studies on the development of
reactive pseudarthroses on the canine radius]. Helv Chir Acta 1968;35:301–8.
[37] Pattappa G, Peroglio M, Sakai D, Mochida J, Benneker LM, Alini M, et al. CCL5/
RANTES is a key chemoattractant released by degenerative intervertebral discs
in organ culture. Eur Cell Mater 2014;27:124–36 discussion 36.
[38] Perren SM, Huggler A, Russenberger M, Allgöwer M, Mathys R, Schenk R, et al.
The reaction of cortical bone to compression Reaktion der Kortikalis auf
Kompression. Acta Orthop Scand Suppl 1969;19–28.
[39] Pirvu T, Blanquer SB, Benneker LM, Grijpma DW, Richards RG, Alini M, et al. A
combined biomaterial and cellular approach for annulus fibrosus rupture
repair. Biomaterials 2015;42:11–9.
[40] Reizner W, Hunter JG, O’Malley NT, Southgate RD, Schwarz EM, Kates SL. A
systematic review of animal models for Staphylococcus aureus osteomyelitis.
Eur Cell Mater 2014;27:196–212.
[41] Sakai D, Nakamura Y, Nakai T, Mishima T, Kato S, Grad S, et al. Exhaustion of
nucleus pulposus progenitor cells with ageing and degeneration of the
intervertebral disc. Nat Commun 2012;3:1264.
[42] Sample SJ, Behan M, Smith L, Oldenhoff WE, Markel MD, Kalscheur VL, et al.
Functional adaptation to loading of a single bone is neuronally regulated and
involves multiple bones. J Bone Mineral Res 2008;23:1372–81.
[43] Schenk R, Willenegger H. (On the histology of primary bone healing.).
Langenbecks ArchKlinChir VerDtschZChir 1964;308:440–52.
[44] Verrier S, Meury TR, Kupcsik L, Heini P, Stoll T, Alini M. Platelet-released
supernatant induces osteoblastic differentiation of human mesenchymal stem
cells: potential role of BMP-2. Eur Cell Mater 2010;20:403–14.
[45] Wirth AJ, Goldhahn J, Flaig C, Arbenz P, Muller R, et al. Implant stability is
affected by local bone microstructural quality. Bone 2011;49:473–8.
[46] Allgower M, Spiegel PG. Internal fixation of fractures: evolution of concepts.
Clin Orthop Relat Res 1979;26–9.
A. Joeris et al. / Injury, Int. J. Care Injured xxx (2019) xxx–xxx 7
G Model
JINJ 8241 No. of Pages 8
Please cite this article in press as: A. Joeris, et al., The impact of the AO Foundation on fracture care: An evaluation of 60 years AO Foundation,
Injury (2019), https://doi.org/10.1016/j.injury.2019.07.016
[47] Fehlings MG, Nater A, Tetreault L, Kopjar B, Arnold P, Dekutoski M, et al.
Survival and clinical outcomes in surgically treated patients with metastatic
epidural spinal cord compression: results of the prospective multicenter AO
spine study. J Clin Oncol 2016;34:268–76.
[48] Friedman SM, Mendelson DA, Bingham KW, Kates SL. Impact of a comanaged
Geriatric Fracture Center on short-term hip fracture outcomes. Arch Intern
Med 2009;169:1712–7.
[49] Goldhahn J, Suhm N, Goldhahn S, Blauth M, Hanson B. Influence of
osteoporosis on fracture fixation–a systematic literature review.
Osteoporosis Int 2008;19:761–72.
[50] Kammerlander C, Roth T, Friedman SM, Suhm N, Luger TJ, Kammerlander-
Knauer U, et al. Ortho-geriatric service–a literature review comparing different
models. Osteoporosis Int 2010;21:S637–46.
[51] Konrad G, Bayer J, Hepp P, Voigt C, Oestern H, Kaab M, et al. Open reduction and
internal fixation of proximal humeral fractures with use of the locking
proximal humerus plate. Surgical technique. J Bone Joint Surg Am 2010;92
(Suppl 1 Pt 1):85–95.
[52] Perren SM. The concept of biological plating using the limited contact-
dynamic compression plate (LC-DCP). Scientific background, design and
application. Injury 1991;22(Suppl 1):1–41.
[53] Perren SM. Evolution of the internal fixation of long bone fractures. The
scientific basis of biological internal fixation: choosing a new balance between
stability and biology. J Bone Joint Surg Br 2002;84:1093–110.
[54] Ruedi T. Fractures of the lower end of the tibia into the ankle joint: results 9
years after open reduction and internal fixation. Injury 1973;5:130–4.
[55] Ruedi T, Matter P, Allgower M. [Intra-articular fractures of the distal tibial end].
Helv Chir Acta 1968;35:556–82.
[56] Rüedi TP, Allgower M. The operative treatment of intra-articular fractures of
the lower end of the tibia. Clin Orthop Relat Res 1979;105–10.
[57] Ruedi TP, Luscher JN. Results after internal fixation of comminuted fractures of
the femoral shaft with DC plates. Clin Orthop Relat Res 1979;74–6.
[58] Jeannet J-P. AO Institutes: Res earch, CDID, ‘Trauma University,’ and a
Publishing House (Chapter 45). Leading a Surgical Revolution The AO
Foundation – Social Entrepreneurs in the Treatment of Bone Trauma. Springer
Nature Switzerland: Cham; 2019. p. 335–50.
[59] Cutler DM, Long G, Berndt ER, Royer J, Fournier AA, Sasser A, et al. The value of
antihypertensive drugs: a perspective on medical innovation. Health Aff
(Project Hope) 2007;26:97–110.
[60] Schneider R. 10 Jahre AO: AO - Dokumentationszentrale Bern, 1969.
[61] Schneider R. 25 Jahre AO-Schweiz - Arbeitsgemeinschaft für Osteosynthesefrage
1958-1983: Arbeitsgemeinschaft fuer Osteosynthesefragen. 1983.
[62] Schlich T. Surgery, science and industry – A revolution in fracture care, 1950s-
1990s. New York: Palgrave MacMillan; 2002.
8 A. Joeris et al. / Injury, Int. J. Care Injured xxx (2019) xxx–xxx
G Model
JINJ 8241 No. of Pages 8
Please cite this article in press as: A. Joeris, et al., The impact of the AO Foundation on fracture care: An evaluation of 60 years AO Foundation,
Injury (2019), https://doi.org/10.1016/j.injury.2019.07.016
